Mapping the Single-Cell Differentiation Landscape of Osteosarcoma.

Area of Science:

• Biomedical research
• Cancer biology
• Stem cell biology

Background:

• Genetic intratumoral heterogeneity in osteosarcoma complicates drug development and understanding of cell fate, plasticity, and differentiation.
• These cellular processes are critical determinants of tumor grade, metastasis, and patient survival.

Purpose of the Study:

• To identify and rectify errors in osteosarcoma (OS) differentiation pathways.
• To establish a comprehensive atlas of human mesenchymal stem cell differentiation.
• To correlate transcriptomic phenotypes with clinical outcomes in osteosarcoma.

Main Methods:

• Transcriptional profiling of 31,527 cells from a tissue-engineered model directing mesenchymal stem cells (MSCs) toward adipogenic and osteoblastic fates.
• Integration of existing chondrocyte data.
• Application of trajectory analysis and non-negative matrix factorization (NMF) to create a human mesenchymal differentiation atlas.
• Projection of bulk RNA-sequencing data from osteosarcoma tumors onto the differentiation atlas.

Main Results:

• Generation of the first human mesenchymal differentiation atlas, serving as a reference for cellular composition and lineage commitment in osteosarcoma.
• Quantification of cellular composition and lineage commitment within morphologically complex osteosarcoma tumors.
• Discovery of a correlation between a stem-like transcriptomic phenotype and poorer survival outcomes in osteosarcoma patients.

Conclusions:

• The study provides a quantitative measure of osteosarcoma differentiation and lineage commitment.
• This detailed atlas is a prerequisite for understanding lineage-specific differentiation bottlenecks.
• Identification of these bottlenecks may lead to future therapeutic strategies for osteosarcoma.